Labcorp Holdings Inc. LH
i
Market dataready · fetched 2026-11-11T14:49:59.937Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:49:02.400105451Z
FundamentalsSEC EDGAR · ready · as of 2026-09-30 · fetched 2026-11-11T14:49:59.339996+00:00
Labcorp Holdings Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 388.83 | 32.1% | 5.2% | 354.79 | 35.7% | 5.2% |
| 25Δ | 385.36 | 30.9% | 4.4% | 359.41 | 33.3% | 4.1% |
| 30Δ | 381.89 | 29.7% | 3.6% | 362.27 | 32.6% | 3.5% |
| 35Δ | 378.99 | 29.1% | 3.1% | 364.88 | 32.1% | 3.0% |
| 40Δ | 376.78 | 29.3% | 2.7% | 367.49 | 31.6% | 2.6% |
| 45Δ | 374.57 | 29.4% | 2.4% | 370.09 | 31.1% | 2.1% |
| 50Δ | 372.36 | 29.6% | 2.1% | 372.47 | 31.2% | 1.8% |
| 55Δ | 370.15 | 29.7% | 1.7% | 374.84 | 31.3% | 1.6% |
| 60Δ | 367.73 | 29.9% | 1.5% | 377.22 | 31.4% | 1.3% |
| 65Δ | 365.30 | 30.1% | 1.3% | 379.59 | 31.6% | 1.0% |
| 70Δ | 362.87 | 30.3% | 1.1% | 382.65 | 31.9% | 0.8% |
| 75Δ | 360.44 | 30.5% | 0.8% | 385.84 | 32.3% | 0.7% |
| 80Δ | 357.05 | 30.7% | 0.7% | 389.04 | 32.7% | 0.5% |
20Δ
- Pseudo strike
- 388.83
- IV
- 32.1%
- B/E move
- 5.2%
- Pseudo strike
- 354.79
- IV
- 35.7%
- B/E move
- 5.2%
25Δ
- Pseudo strike
- 385.36
- IV
- 30.9%
- B/E move
- 4.4%
- Pseudo strike
- 359.41
- IV
- 33.3%
- B/E move
- 4.1%
30Δ
- Pseudo strike
- 381.89
- IV
- 29.7%
- B/E move
- 3.6%
- Pseudo strike
- 362.27
- IV
- 32.6%
- B/E move
- 3.5%
35Δ
- Pseudo strike
- 378.99
- IV
- 29.1%
- B/E move
- 3.1%
- Pseudo strike
- 364.88
- IV
- 32.1%
- B/E move
- 3.0%
40Δ
- Pseudo strike
- 376.78
- IV
- 29.3%
- B/E move
- 2.7%
- Pseudo strike
- 367.49
- IV
- 31.6%
- B/E move
- 2.6%
45Δ
- Pseudo strike
- 374.57
- IV
- 29.4%
- B/E move
- 2.4%
- Pseudo strike
- 370.09
- IV
- 31.1%
- B/E move
- 2.1%
50Δ
- Pseudo strike
- 372.36
- IV
- 29.6%
- B/E move
- 2.1%
- Pseudo strike
- 372.47
- IV
- 31.2%
- B/E move
- 1.8%
55Δ
- Pseudo strike
- 370.15
- IV
- 29.7%
- B/E move
- 1.7%
- Pseudo strike
- 374.84
- IV
- 31.3%
- B/E move
- 1.6%
60Δ
- Pseudo strike
- 367.73
- IV
- 29.9%
- B/E move
- 1.5%
- Pseudo strike
- 377.22
- IV
- 31.4%
- B/E move
- 1.3%
65Δ
- Pseudo strike
- 365.30
- IV
- 30.1%
- B/E move
- 1.3%
- Pseudo strike
- 379.59
- IV
- 31.6%
- B/E move
- 1.0%
70Δ
- Pseudo strike
- 362.87
- IV
- 30.3%
- B/E move
- 1.1%
- Pseudo strike
- 382.65
- IV
- 31.9%
- B/E move
- 0.8%
75Δ
- Pseudo strike
- 360.44
- IV
- 30.5%
- B/E move
- 0.8%
- Pseudo strike
- 385.84
- IV
- 32.3%
- B/E move
- 0.7%
80Δ
- Pseudo strike
- 357.05
- IV
- 30.7%
- B/E move
- 0.7%
- Pseudo strike
- 389.04
- IV
- 32.7%
- B/E move
- 0.5%
Options history
Table
| Date | IV (%) |
|---|---|
| 26.95% | |
| 26.92% | |
| 26.97% | |
| 27.00% | |
| 27.05% | |
| 27.51% | |
| 27.31% | |
| 22.98% | |
| 23.12% | |
| 24.46% |
Diagnostics & Research
MEDP
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. The company is headquartered in…
More →MTD
Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments. It is the largest provider of weighing instruments for use in laboratory,…
More →MYGN
Myriad Genetics, Inc., a molecular diagnostics company, develops and markets predictive, personalized, and prognostic medicine tests in the United States and internationally. The…
More →NEO
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
More →NTRA
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
More →OPK
Description unavailable
More →